Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950135-04-003085
Filing Date
2004-06-14
Accepted
2004-06-14 15:43:13
Documents
1
Group Members
ABINGWORTH BIOVENTURES III A L.P.ABINGWORTH BIOVENTURES III B L.P.ABINGWORTH BIOVENTURES III C L.PABINGWORTH BIOVENTURES III EXECUTIVES L.P.

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. b50875amsc13g.txt SC 13G 25156
  Complete submission text file 0000950135-04-003085.txt   27184
Mailing Address 790 MEMORIAL DR CAMBRIDGE MA 02139
Business Address 790 MEMORIAL DR CAMBRIDGE MA 02139 6172520700
ALNYLAM PHARMACEUTICALS INC (Subject) CIK: 0001178670 (see all company filings)

EIN.: 770602661
Type: SC 13G | Act: 34 | File No.: 005-79884 | Film No.: 04861456
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 20 7534 1508
Abingworth Management LTD (Filed by) CIK: 0001291892 (see all company filings)

EIN.: 000000000